Rouffy, J <br/><br/>
Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).  [electronic resource] 

 -  Arzneimittel-Forschung  1976 
 - 901-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0004-4172 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Clofibrate--therapeutic use<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Hypercholesterolemia--drug therapy<br/>Hyperlipidemias--drug therapy<br/>Hypolipidemic Agents--therapeutic use<br/>Lipoproteins, LDL--blood<br/>Lipoproteins, VLDL--blood<br/>Male<br/>Middle Aged<br/>Propionates--therapeutic use<br/>Triglycerides--blood